You are here

Spinal metastazh malign melanomalarin nörolojik bulguları

Neurological Manifestation of Spinal Metastasis of Malignant Melanoma : Clinical Analysis of 26 Patients

Journal Name:

Publication Year:

Keywords (Original Language):

Abstract (2. Language): 
Although malignant melanoma is one of the most common causes of central nervous system metastases, spinal metastases from it are relatively rare. Despite spinal metastases primarily are not fatal, they may be catastrophic because of ambulation loss and sphincter disturbances. The purpose of this study was to review the course of this illnes after the development of neurological deficits and to asses the efficiacy of radiation therapy on symptoms and signs of spinal metastasis. 26 patients with neurological manifestations from spinal metastasis of melanoma were analyzed retrospectively. Median age of the patients was 48 years (range 24-87). Fifteen patients had cord compression by epidural metastasis, 6 patients had intramedullary, and 5 patients had leptomenengial metastasis. 17 of these patients suffered from pain. In 12 patients, first symptom was neurological disturbance, while in 14 patients it was pain. In patients who received radiotherapy for pain, in 5 patients pain improved, in 13 patients remained unchanged, in 2 patients worsened. In patients who received radiotherapy for neurological deficits, in 9 patients deficit improved, in 7patients worsened, in 10 patients did not change. While radiotherapy had significant effect on neurological recovery (p<0.03), it did not have any effect on pain. [Journal of Turgut Özal Medical Center 1997;4(1):21-25]
Abstract (Original Language): 
Merkezi sinir sistemine sıklıkla metastaz yapan tümörlerden biri olmasına rağmen, malign melanomalarin spinal metastazları kısmen nadirdir. Primer olarak ölümcül olmayan spinal metastazlar, hastanın ambülasyonımda bozukluklara ve sfinkter kusurlarına neden olarak, oldukça sıkıntılı bir tablo oluşturabilirler. Bu çalışmanın amacı, bu hastalığın, nörolojik tablo geliştikten sonraki seyrini belirliyerek, radyoterapinin semptomlar ve nörolojik bozukluklar üzerine etkinliğini araştırmaktır. Malign melanoma'nın spinal metastazının, nörolojik bozukluk yaptığı 26 hasta retrospektif olarak analiz edildi. Median yaş 48 'di (24-87 arası). 15 hastada epidural metastaza bağlı kord kompresyonu, 6 hastada intrameduller, 5 hastada leptomenenjial metastaz vardı. Bu hastaların 17'sinde ağrı şikayeti mevcuttu. 12 hastanın ilk şikayeti nörolojik bozukluklar iken, 14 hastada ilk şikayet ağrıydı. Ağrı şikayeti olup ta radyoterapi yapılan hastaların 5'inde ağrı kayboldu veya azaldı, 13'ünde değişmedi, 2'sinde arttı. Radyoterapi yapılan hastaların, 9'unda nörolojik defisitler düzelirken, 7'sinde arttı, 10'unda değişmedi. Radyoterapinin, nörolojik düzelme üzerine önemli derecede etkisi varken (p<0.03), ağrı üzerine herhangi bir etkisi olmadığı saptandı. [Turgut Özal Tıp Merkezi Dergisi 1997;4(1):21-25]
21-25

REFERENCES

References: 

1. Boland P, Lane JM, Sundaresan N. Metastatic disease of the spine. Clin Orthop 1982; 169: 95-102.
2. Harrington KD. Anterior decompression and stabilization of the spine as a treatment for vertebral collapse and spinal cord compression from metastatic malignancy. Clin Orthop 1988; 233: 177-97.
3. Patten RM, Shuman WP, Teefey S. Metastases from malignant melanoma to the axial skeleton: A CT study of frequency and appearance. AJR 1992; 155: 109-12.
4. Wong DA, Fornasier VL, Mac Nab I. Spinal metastases: The obvious, the occult, and the impostors. Spine 1990;15:
1- 4.
5. Dickie LE. Melanoma: Research report National Cancer
Institue. NIH publication 1988; 89: 3020.
6. Fritischi L, Coates M, Mc Credie M. Incidence of cancer among new south wales adolescents: Which classification scheme describes adolescent cancer better. Int J Cancer
1990; 60: 355-60.
7. Rigel DS, Kopt AW, Friedman RJ. The rate of malignant melanoma in the United States: Are we making an impact? J
Am Acad Dermatol 1987; 17: 1050-3.
8. Silverberg E, Lubera J. Cancer statistics 1987. CA 1987; 37:
2- 19.
9. Black P. Spinal metastasis: Current status and recommended guidelines for management. Neurosurgery 1979;5: 726-46.
10. Neilan BA. Metastatic spinal cord compression. Am Fam
Phys 1983; 27: 191-4.
11. Posner JB. Neurologic complications of systemic cancer.
DM 1978; 25: 1-60.
12. Sundaresan N, Digiacinto GV, Hughes JEO, et al. Treatment of neoplastic spinal cord compression: Results of prospective study. Neurosurgery 1991; 29: 645-50.
13. Greenberg HL, Kim JH, Posner JB. Epidural spinal cord compression from metastatic tumor: Results with a new treatment protocol. Ann Neurol 1980; 8: 361-6.
14. Patchell RA, Posner JB. Neurologic complications of systemic cancer. Neurologic Clinics 1985; 3: 729-50.
15. Mullins GM, Flynn JPG, El-Mahdi A, et al. Malignant
lymphoma of the spinal epidural space. Ann Intern Med
1971; 74: 416-23.
16. Patel JK, Didolkar MS, Pickran JW, Moore RH. Metastatic
pattern of malignant melanoma: A study of 216 autopsy
cases. Am J Surg 1978; 135:807-10.
17. Vergen E, Conili C, Vila A, et al. Contribution of magnetic resonance 1992;26: 329-31.
18. Algra PR, Heimans JJ, Valk J, et al. Do metastases in vertebra begin in the body or the pedicles ? Imaging study in 45 patients. AJR imaging in the early diagnosis of epidural
metastasis. Med Clin (Bare) 1992; 158: 1275-9.
19. Constants JP, Divitish E, Donzelli R, et al. Spinal metastases with neurological manifestations: Rewiev of 600
cases. J Neurosurg 1987; 59: 111-8.
20. Stark RJ, Henson RA, Evans JW. Spinal metastases: A retrospective survey from a General Hospital. Brain 1982;
105: 189-213.
21. Perrin RG: Metastatic tumors of the axial spine. Curr Opin
Oncol 1992; 4: 525-32.
22. Sunderasen N, Galicich JH, Lane JM, et al. Treatment of neoplastic epidural cord compression by vertebral body resection and stabilization. J Neurosurg 1985;63: 676-84.
23. Rodickhock LD, Harper GR, Ruckdeschel JC, et al. Early diagnosis of spinal epidural metastases. AMJ Med 1981;70:
1181-8.
24. Barron KD, Hirano A, Araki S, Terry RD. Experiences with metastatic neoplasm involving the spinal cord. Neurology 1959;9: 91-106.
25. Grem JL, Burgess J, Trump DL. Clinical features and natural history of intramedullary spinal cord metastasis. Cancer 1985; 56: 2305-14.
26. Costigan DA, Winkelman MD. Intramedullary spinal cord metastasis: A clinicopathological study. J Neurosurg 1985;62: 227-33.
27. Rate WR, Solin LJ, Turrisi AJ. Palliative radiotherapy for metastatic malignant melanoma: Brain metastases, bone metastases and spinal cord compression. Int J Radiation
Oncology Biol Phys 1988;15: 859-64.
28. Tokuhashi Y, Matsuzaki H, Toriyama S, et al. Scoring system for the preoperative evaluation of metastatic spine tumor prognosis. Spine 1990;15: 1110-3.
29. Pyrhonen S, Kouni M, Holsti LR, Cantell K. Disease stabilization by leukocyte alpha interferon and survival of patients with metastatic melanoma. Oncology 1992;49: 22¬6.
30. Aapro MS. Advences in systemic of malignant melanoma. Eur J Cancer 1985;29 A: 613-7.

Thank you for copying data from http://www.arastirmax.com